Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock Common Class A	Common Stock Common Class B	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income	Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity, beginning balance	$ (134,747)	$ 0	$ 0	$ 67,168	$ (206,005)	$ 4,090
Temporary equity, beginning balance (in shares) at Jan. 31, 2020	79,959,000
Temporary equity, beginning balance at Jan. 31, 2020	$ 425,146
Temporary equity, ending balance (in shares) at Oct. 31, 2020	79,959,000
Temporary equity, ending balance at Oct. 31, 2020	$ 425,146
Equity, beginning balance (in shares) at Jan. 31, 2020		1,151,000	49,338,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock related to vested exercised stock options			507,000
Issuance of common stock related to vested exercised stock options	889			889
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)			535,000
Vesting of early exercised stock options	1,882			1,882
Stock-based compensation expense	5,678			5,678
Foreign currency translation adjustments	(13,300)					(13,300)
Net loss	(72,156)				(72,156)
Equity, ending balance (in shares) at Oct. 31, 2020		1,151,000	50,380,000
Equity, ending balance at Oct. 31, 2020	(211,754)	$ 0	$ 0	75,617	(278,161)	(9,210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity, beginning balance	$ (190,359)	$ 0	$ 0	72,486	(249,553)	(13,292)
Temporary equity, beginning balance (in shares) at Jul. 31, 2020	79,959,000
Temporary equity, beginning balance at Jul. 31, 2020	$ 425,146
Temporary equity, ending balance (in shares) at Oct. 31, 2020	79,959,000
Temporary equity, ending balance at Oct. 31, 2020	$ 425,146
Equity, beginning balance (in shares) at Jul. 31, 2020		1,151,000	49,755,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock related to vested exercised stock options			207,000
Issuance of common stock related to vested exercised stock options	503			503
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)			418,000
Vesting of early exercised stock options	572			572
Stock-based compensation expense	2,056			2,056
Foreign currency translation adjustments	4,082					4,082
Net loss	(28,608)				(28,608)
Equity, ending balance (in shares) at Oct. 31, 2020		1,151,000	50,380,000
Equity, ending balance at Oct. 31, 2020	(211,754)	$ 0	$ 0	75,617	(278,161)	(9,210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity, beginning balance	(211,754)	0	0	75,617	(278,161)	(9,210)
Equity, beginning balance	$ (231,222)	$ 0	$ 0	186,892	(398,199)	(19,915)	$ 0
Temporary equity, beginning balance (in shares) at Jan. 31, 2021	79,551,000
Temporary equity, beginning balance at Jan. 31, 2021	$ 424,904
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of convertible preferred stock to Class B common stock upon initial public offering (in shares)	(79,551,000)
Conversion of convertible preferred stock to Class B common stock upon initial public offering	$ (424,904)
Temporary equity, ending balance (in shares) at Oct. 31, 2021	0
Temporary equity, ending balance at Oct. 31, 2021	$ 0
Equity, beginning balance (in shares) at Jan. 31, 2021		1,151,000	52,468,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of convertible preferred stock to Class B common stock upon initial public offering (in shares)			79,551,000
Conversion of convertible preferred stock to Class B common stock upon initial public offering	424,904			424,904
Conversion of Class B common stock to Class A common stock by the selling stockholder upon initial public offering (in shares)		2,500,000	(2,500,000)
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs (in shares)		8,940,000
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs	649,845			649,845
Repurchase of common stock (in shares)			(13,000)
Repurchase of common stock	$ (590)			(590)
Issuance of common stock related to vested exercised stock options	2,539,000		1,881,000
Issuance of common stock related to vested exercised stock options	$ 8,992			8,992
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)			568,000
Vesting of early exercised stock options	5,425			5,425
Stock-based compensation expense	17,242			17,242
Foreign currency translation adjustments	19,157
Capital contributions from noncontrolling interest holders	26,450						26,450
Net loss	(110,796)				(109,353)		(1,443)
Equity, ending balance (in shares) at Oct. 31, 2021		12,591,000	131,955,000
Equity, ending balance at Oct. 31, 2021	809,407	$ 0	$ 0	1,292,710	(507,552)	(758)	25,007
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity, beginning balance	$ (250,485)	$ 0	$ 0	200,838	(466,325)	(10,526)	25,528
Temporary equity, beginning balance (in shares) at Jul. 31, 2021	79,551,000
Temporary equity, beginning balance at Jul. 31, 2021	$ 424,904
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of convertible preferred stock to Class B common stock upon initial public offering (in shares)	(79,551,000)
Conversion of convertible preferred stock to Class B common stock upon initial public offering	$ (424,904)
Temporary equity, ending balance (in shares) at Oct. 31, 2021	0
Temporary equity, ending balance at Oct. 31, 2021	$ 0
Equity, beginning balance (in shares) at Jul. 31, 2021		1,151,000	53,893,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of convertible preferred stock to Class B common stock upon initial public offering (in shares)			79,551,000
Conversion of convertible preferred stock to Class B common stock upon initial public offering	424,904			424,904
Conversion of Class B common stock to Class A common stock by the selling stockholder upon initial public offering (in shares)		2,500,000	(2,500,000)
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs (in shares)		8,940,000
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs	649,845			649,845
Issuance of common stock related to vested exercised stock options			856,000
Issuance of common stock related to vested exercised stock options	4,572			4,572
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)			155,000
Vesting of early exercised stock options	3,972			3,972
Stock-based compensation expense	8,579			8,579
Foreign currency translation adjustments	9,768					9,768
Net loss	(41,748)				(41,227)		(521)
Equity, ending balance (in shares) at Oct. 31, 2021		12,591,000	131,955,000
Equity, ending balance at Oct. 31, 2021	809,407	$ 0	$ 0	1,292,710	(507,552)	(758)	25,007
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity, beginning balance	$ 809,407	$ 0	$ 0	$ 1,292,710	$ (507,552)	$ (758)	$ 25,007